Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

60%(3 trials)

Phase Distribution

Ph phase_3

40%

Ph phase_1

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 1Safety & dosage

3(60.0%)

Phase 3Large-scale testing

2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 13 (60.0%)

Phase 32 (40.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials

Showing 5 of 5

completedphase_3

Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone

NCT02777268

completedphase_1

Bioavailability of Infacort When Administered Onto Food Compared to Direct Oral Administration

NCT03178214

Clinical Trials (5)

Showing 5 of 5 trials

NCT02720952Phase 3

Treatment of Adrenal Insufficiency in Children

Completed

NCT02733367Phase 3

Extension Study for Patients Entered Into Study Infacort 003

Completed

NCT03311932Phase 1

A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects

Completed

NCT02777268Phase 1

Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone

Completed

NCT03178214Phase 1

Bioavailability of Infacort When Administered Onto Food Compared to Direct Oral Administration

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5